Skip to main content
OpenTrials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

357 public trials 121 recruiting studies
Refine in advanced search Browse all conditions

NSCLC trial results

Completed

A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment

NCT03513666

Conditions
NSCLC
Locations
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Shanghai Pulmonary Hospita Shanghai, Shanghai Municipality, China
  • Tangdu Hospital Xi’an, Shanxi, China
  • The First Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

NCT03164772

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Research Facility Gilbert, Arizona, United States
  • Research Facility Tampa, Florida, United States
  • Research Facility Detroit, Michigan, United States
  • Research Facility New York, United States
View Trial Details
Completed

A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors

NCT03965845

Conditions
CRC, KRAS Gene Mutation, NSCLC, +1 more
Locations
  • UCLA Hematology/Oncology Santa Monica, California, United States
  • Emory, Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Afatinib in NSCLC With HER2 Mutation

NCT02369484

Conditions
NSCLC
Locations
  • Universitätsklinikum Köln Cologne, Germany
  • NKI-AVL Amsterdam, Netherlands
  • Vall d'Hebron University Hospital Barcelona, Spain
  • CHUV Lausanne, Switzerland
View Trial Details

Related conditions